These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1031024)

  • 1. [The effect of bretylium tosylat on the human atrio-ventricular and intraventricular conduction].
    Abate G; Zacà F; Polimeni RM; Alberici S
    Boll Soc Ital Cardiol; 1976; 21(4):601-8. PubMed ID: 1031024
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
    Patterson E; Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1981 Mar; 216(3):453-8. PubMed ID: 7205624
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the electrophysiological properties of bretylium tosylate in man].
    Touboul P; Porte J; Huerta F; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 May; 69(5):503-11. PubMed ID: 821420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug therapy: bretylium.
    Koch-Weser J
    N Engl J Med; 1979 Mar; 300(9):473-7. PubMed ID: 366419
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiologic effects of bretylium on canine ventricular muscle during acute ischemia and reperfusion.
    Fujimoto T; Hamamoto H; Peter T; McCullen A; McCullen A; Melvin N; Mandel WJ
    Am Heart J; 1983 Jun; 105(6):966-72. PubMed ID: 6858845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic antagonism of quinidine and bretylium tosylate.
    De Azevedo IM; Wantanabe Y; Dreifus LS
    Am J Cardiol; 1974 May; 33(5):633-8. PubMed ID: 4820895
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
    Gibson JK; Stewart JR; Li YP; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Kabell G
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bretylium (Bretylol) for ventricular arrhythmias.
    Med Lett Drugs Ther; 1978 Dec; 20(24):105-6. PubMed ID: 713969
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrophysiologic effects of bretylium tosylate on single fibers of the canine specialized conducting system and ventricle.
    Wit AL; Steiner C; Damato AN
    J Pharmacol Exp Ther; 1970 Jun; 173(2):344-56. PubMed ID: 4393574
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of bretylium tosylate in a single bolus and in different doses on various electrophysiological parameters].
    Chiariello M; Santinelli V; Ferro G; Stanislao M; Giunta A; Condorelli M
    Boll Soc Ital Cardiol; 1979; 24(7):747-51. PubMed ID: 554660
    [No Abstract]   [Full Text] [Related]  

  • 12. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential blockade of chronotropic responses to cardiac sympathetic nerve stimulation with bretylium.
    Priola DV; Weiss GK; Spurgeon HA
    Proc West Pharmacol Soc; 1977; 20():421-6. PubMed ID: 896849
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study.
    Koo CC; Allen JD; Pantridge JF
    Cardiovasc Res; 1984 Dec; 18(12):762-7. PubMed ID: 6518459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane action and catecholamine release action of bretylium tosylate in normoxic and hypoxic canine Purkinje fibers.
    Nishimura M; Watanabe Y
    J Am Coll Cardiol; 1983 Aug; 2(2):287-95. PubMed ID: 6863763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bretylium tosylate as an anti-arrhythmic drug].
    Steffen V; Fiehring H
    Z Gesamte Inn Med; 1976 Nov; 31(22):913-9. PubMed ID: 798429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic effects of bretylium tosylate on the heart.
    Waxman MB; Wallace AG
    J Pharmacol Exp Ther; 1972 Nov; 183(2):264-74. PubMed ID: 5083545
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with bretylium tosylate].
    Steffen V; Assmann I; Fiehring H
    Z Gesamte Inn Med; 1976 Sep; 31(17):684-8. PubMed ID: 793213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bretylium: a prototype for future development of antidysrhythmic agents.
    Patterson E; Lucchesi BR
    Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of bretylium tosylate on the intraocular pressure of the rabbit.
    Krieglstein GK
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Nov; 197(2):153-8. PubMed ID: 1082263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.